Upstream Processing

Oct 01, 2018
BioPharm International
The maturation of single-use technologies presents commercial bioprocessing options for small-volume drug products.
Oct 01, 2018
By BioPharm International Editors
The companies partnered to build a 500-L single-use pilot-scale plant for biologics production.
Sep 17, 2018
By BioPharm International Editors
The provider of plant-based ingredients will present recently launched multi-compendial materials for upstream and downstream biopharmaceutical applications.
Sep 07, 2018
By BioPharm International Editors
New products were developed as next-generation process intensification technologies, MilliporeSigma reports.
Sep 01, 2018
BioPharm International
Trace elements in raw materials may impact the quality and safety of the finished biologic product, according to industry experts.
Sep 01, 2018
BioPharm International
Sharing of bioprocessing know-how can help resolve pressing industry problems.
Aug 01, 2018
BioPharm International
The quality of the cell lines used to manufacture biopharmaceuticals are crucial for the production of high-quality, stable biopharmaceuticals.
Aug 01, 2018
BioPharm International
Biopharma seeks alternatives that meet the needs for next-gen biologic drug production.
Jul 01, 2018
BioPharm International
Late-stage and commercial biomanufacturing pose a challenge to cell-culture processing.
Jul 01, 2018
BioPharm International
Biopharma companies can balance competing demands from patients, investors, and regulators by keeping a focus on science.
native1_300x100
lorem ipsum